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Abstract 
Background: In an effort to improve surveillance for epidemiological and clinical outcomes, rapid diagnostic tests 
(RDTs) have become increasingly widespread as cost-effective and field-ready methods of malaria diagnosis. However, 
there are concerns that using RDTs specific to Plasmodium falciparum may lead to missed detection of other malaria 
species such as Plasmodium malariae and Plasmodium ovale.
Methods: Four hundred and sixty six samples were selected from children under 5 years old in the Democratic 
Republic of the Congo (DRC) who took part in a Demographic and Health Survey (DHS) in 2013–14. These samples 
were first tested for all Plasmodium species using an 18S ribosomal RNA-targeted real-time PCR; malaria-positive sam-
ples were then tested for P. falciparum, P. malariae and P. ovale using a highly sensitive nested PCR.
Results: The prevalence of P. falciparum, P. malariae and P. ovale were 46.6, 12.9 and 8.3 %, respectively. Most P. malar-
iae and P. ovale infections were co-infected with P. falciparum—the prevalence of mono-infections of these species 
were only 1.0 and 0.6 %, respectively. Six out of these eight mono-infections were negative by RDT. The prevalence of 
P. falciparum by the more sensitive nested PCR was higher than that found previously by real-time PCR.
Conclusions: Plasmodium malariae and P. ovale remain endemic at a low rate in the DRC, but the risk of missing 
malarial infections of these species due to falciparum-specific RDT use is low. The observed prevalence of P. falciparum 
is higher with a more sensitive PCR method.
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Background
Malaria remains a severe global burden, causing an esti-
mated 214 million cases and 438,000 deaths in 2015 [1], 
a toll that is particularly high in sub-Saharan Africa. 
Efforts to control malaria depend on diagnostic accuracy 
and availability, and in recent years the demand for rapid 
diagnostic tests (RDTs) has been increasingly high. RDTs 
detect malaria antigens in the blood using immuno-
chromatography. They provide an easy-to-use alterna-
tive to microscopy, which requires skilled experts to be 
optimally effective [2, 3], and a cost-effective and field-
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Among the most widely used RDTs are those that 
detect Plasmodium falciparum histidine-rich protein 2 
(PfHRP2). These RDTs are sensitive and specific for para-
sitaemias above 200 per µl blood [5]. RDTs that use the 
Plasmodium lactate dehydrogenase (pLDH) antigen are 
designed to detect all species of malaria, but are less sen-
sitive [6–8].
In sub-Saharan Africa, where the vast majority of 
malaria infections are due to P. falciparum [1], RDTs 
detecting PfHRP2 are most commonly used. However, 
mono-infections with non-falciparum malarias (pri-
marily Plasmodium malariae and Plasmodium ovale in 
sub-Saharan Africa) may go undetected. In this study, 
a sub-set of samples from a nationally representative, 
cross-sectional study of children under age 5  years in 
the Democratic Republic of the Congo (DRC) were used 
to determine the prevalence of P. malariae and P. ovale 
mixed and mono-infections, and to assess the risk of 
missed detection due to the use of falciparum-specific 
RDTs.
Methods
Survey methodology and sample collection
The 2013–14 Demographic and Health Survey (DHS) was 
a cluster-based household survey in the DRC, which took 
place between November 2013 and February 2014. As 
part of the survey, blood samples collected from children 
under 5 years of age were analysed for malaria infection, 
without speciation, by light microscopy. The samples 
were also tested with an RDT targeting PfHRP2 (SD Bio-
line Malaria Ag P.f., Standard Diagnostics, Gyeonggi-do, 
Republic of Korea) and used to make dried blood spots 
(DBS). From DBS, DNA was extracted and tested for P. 
falciparum infection using a real-time PCR assay tar-
geting the P. falciparum lactate dehydrogenase (pfldh) 
gene as previously described [9, 10]. This research was 
approved by institutional review boards at the Kinshasa 
School of Public Health and the University of North Car-
olina at Chapel Hill. Informed consent was obtained from 
a parent or responsible adult for all subjects.
Samples for this study were randomly chosen from four 
strata: (1) microscopy-positive, pfldh PCR-negative; (2) 
microscopy-negative, pfldh PCR-negative; (3) micros-
copy-positive, pfldh PCR-positive; and, (4) micros-
copy-negative, pfldh PCR-positive (Table  1). To detect 
a prevalence of 1 % (0, 2, 95 % confidence interval), the 
minimum sample size was estimated as 362 [11].
All‑Plasmodium real‑time PCR assay
Samples that initially tested negative by pfldh PCR 
underwent a real-time PCR assay that detects all species 
of Plasmodium, targeting the gene encoding the small 
sub-unit (18S) of the ribosomal RNA gene (heretofore 
referred to as “All Plasmodium qPCR”). Primer and probe 
sequences, reaction mixture and cycling conditions for 
this assay were previously published [12] with the excep-
tion that Probe Master qPCR Mix (Roche, Indianapolis, 
IN, USA) was used (Additional file  1: Table  S1). Each 
sample was tested in duplicate. A sample was considered 
positive for Plasmodium if both of its replicates amplified 
or if one replicate amplified with a cycle threshold (CT) 
value lower than 38.
Speciation by BLAST
Samples that tested positive in the All Plasmodium 
qPCR assay were speciated using Sanger sequencing and 
BLAST. DNA was amplified by nested PCR of Plasmo-
dium 18S rDNA as previously described [13], with the 
outer primers rPLU1 and rPLU5 and the inner, genus-
specific primers rPLU3 and rPLU4. Primer sequences 
and reaction conditions are listed in Additional file  1: 
Table S1.
Products from this nested PCR were Sanger sequenced 
(Eton Bioscience, Durham, NC, USA) and queried in the 
BLAST database (National Center for Biotechnology 
Information, Bethesda, MD, USA). If a sequence pro-
duced a result with at least 50  % query cover and 94  % 
identity, it was identified as the species with the best 
match. Otherwise, if a result produced 10 % query cover 
and 80  % identity, the cleanest part of the sequence, as 
determined by the authors, was resubmitted to BLAST 
and if this search fulfilled the initial criteria the species 
was defined. All sequences that did not produce such a 
match were labelled ‘indeterminate’ by this method.
Speciation by species‑specific nested PCR
Samples that were malaria-positive by either the pfldh 
qPCR or the All Plasmodium qPCR were tested using 
species-specific nested PCR as in [13]. The Round 1 reac-
tion used the same primers as used in the genus-specific 
nested PCR but with Qiagen HotStarTaq Master Mix 
(Qiagen, Hilden, Germany) (Additional file 1: Table S1).
Separate Round 2 reactions were run for P. falciparum 
(primers rFAL1 and rFAL2), P. malariae (rMAL1 and 
rMAL2), and P. ovale (rOVA1 and rOVA2) (see Addi-
tional file  1: Table  S1). The PCR products from each 
Table 1 Sampling strata used in this study
Strata Total size Sampled Fraction (%)
Microscopy+/PCR− 216 15 6.9
Microscopy−/PCR− 4169 301 7.2
Microscopy+/PCR+ 1695 89 5.3
Microscopy−/PCR+ 1057 61 5.8
Total 7137 466 6.5
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speciation reaction were analysed by gel electrophoresis 
on a 3 % agarose gel to determine positivity for each spe-
cies in each sample. Samples that did not amplify for any 
of the three species were labelled ‘indeterminate’ by this 
method.
The species of each sample was determined based on 
results from nested PCR. If a sample was indeterminate 
by nested PCR, the BLAST result was used instead. If the 
BLAST result was also indeterminate, the sample was 
removed from the analysis.
Analysis
Data were entered and analysed in Microsoft Excel 2007 
(Microsoft, Redmond, WA, USA). Weighted prevalence 
were calculated as follows: for each stratum the propor-
tion of positive samples in the sub-set was multiplied by 
the number of samples in the stratum. The sum of these 
was divided by the total number of samples.
Results
Study population
There were 7137 children under 5 years old with known 
pfldh PCR, microscopy and RDT results. Of these, a total 
of 466 samples (6.5 %) were chosen from the four strata 
listed in Table 1 for use in this study. A sample flow dia-
gram is shown in Additional file 1: Figure S1.
All Plasmodium qPCR
Among the 316 samples that were negative by pfldh PCR, 
52 samples were malaria-positive by the All Plasmodium 
qPCR assay—nine microscopy-positive and 43 micros-
copy-negative. Including these and 150 samples that were 
positive by pfldh PCR, a total of 202 malaria-positive 
samples was analysed for speciation. Out of these, four 
(2.0 %) were indeterminate (Table 2), giving an analysable 
population of 198 malaria-positive samples and 462 total 
samples.
Prevalence of Plasmodium falciparum
Of 198 malaria-positive samples, 190 (96.0 %) were posi-
tive for P. falciparum, giving a weighted prevalence in 
the survey sample set of 46.6  % (95  % CI 44.4–48.9  %) 
(Table  2). This is slightly higher than the prevalence of 
38.6 % by the initial PCR test (pfldh) [10].
Prevalence of Plasmodium malariae and Plasmodium ovale
Of 198 samples, 52 (26.3 %) were positive for P. malariae 
and 34 (17.2 %) were positive for P. ovale, giving weighted 
prevalence of 12.9  % (95  % CI 10.0–15.9  %) and 8.3  % 
(95 % CI 5.7–10.8 %), respectively (Table 2). Geographi-
cal distributions of P. malariae and P. ovale infections are 
shown in Fig. 1. Both P. malariae and P. ovale infections 
are widely distributed. Eighty-nine percent of individuals 
with P. malariae or P. ovale infection were also infected 
with P. falciparum.
Five P. malariae mono-infections and three P. ovale 
mono-infections were found, giving weighted prevalence 
of 1.0 % (95 % CI 0.1–1.8 %) and 0.6 % (95 % CI 0–1.3 %), 
respectively. Of these eight non-P. falciparum mono-
infections, six (75.0 %) were negative by RDT.
Discussion
Using a sub-set of 462 samples from the large, cross-
sectional DHS, the prevalence of P. malariae and P. ovale 
among children in the DRC was found to be 12.9 and 
8.3  %, respectively, with widespread geographical dis-
tributions seen in both species. A recent study of chil-
dren in Western Kasai, DRC found a similar prevalence 
of P. malariae (13.8 %) but a lower prevalence of P. ovale 
(2.4 %) [14], and another study of asymptomatic individu-
als in six provinces of the DRC found a much lower preva-
lence of P. malariae (1.0 %) [15]. In 2007 prevalence were 
4.9 % for P. malariae and 0.6 % for P. ovale [16]. In gen-
eral, prevalence found here are higher than those reported 
in other African countries for P. malariae [17–20] and P. 
ovale [17, 18, 21]. However, all of these differences could 
be due to normal geographic and temporal variations as 
well as differences in the PCR and sampling methods.
Mono-infections of P. malariae and P. ovale appear 
to be rare in the DRC. In this study, the mono-infection 
prevalence were only 1.0 and 0.6 %, respectively. In West-
ern Kasai, there were no P. malariae or P. ovale mono-
infections reported [14].
Because HRP2-based RDTs detect P. falciparum only, 
they can result in missed detection of P. malariae and 
P. ovale mono-infections. Of the eight mono-infections 
found here, six were negative by RDT. The remaining 
two were likely recently cleared P. falciparum infec-
tions in which the HRP2 antigen was still present, as it 
can remain in the blood stream for up to 1 month after 
parasite clearance [22]. Overall, the number of non-fal-
ciparum infections missed by the RDT was small as most 
such cases were co-infections with P. falciparum.
Of 316 samples that were initially negative by pfldh 
PCR, 52 amplified P. falciparum 18S rDNA by nested 
species-specific PCR. As a result, the PCR preva-
lence using both tests was higher (46.6 %) than found 
using a single test (38.6  %). This is likely because the 
18S rDNA assay has a lower threshold of detection. 
Thus, caution must be used when comparing preva-
lence rates determined using different PCR and survey 
methodologies.
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Conclusions
Plasmodium falciparum remains the most preva-
lent species of malaria in the DRC, but P. malariae 
and P. ovale are endemic at a low rate. While RDTs 
have limitations, the results presented here suggest 
that the risk of missing malarial infections because 
they are mono-infections of P. malariae and P. ovale 
is low. However, the development of new RDTs to 
cover non-falciparum malaria will improve efforts at 
elimination.











Negative 6 258 – – 264
Positive 9 43 89 61 202
Species-specific PCR
P. falciparum only 4 24 48 49 125
P. malariae only 0 5 0 0 5
P. ovale only 1 2 0 0 3
P. falciparum + P. malariae 4 2 23 5 34
P. falciparum + P. ovale 0 7 9 2 18
P. falciparum + P. malariae + P. ovale 0 0 9 4 13
Mono-infections + Mixed
P. falciparum total 8 33 89 60 190
P. malariae total 4 7 32 9 52
P. ovale total 1 9 18 6 34
Indeterminate 0 3 0 1 4
Total 15 301 89 61 466
Fig. 1 Geographical distribution of Plasmodium malariae (a) and Plasmodium ovale (b) cases by DHS cluster. For each cluster, the size of the black 
dot represents the number of cases tested (out of a total 462) and the size of the red dot represents the number of positive P. malariae (a) or P. ovale 
(b) cases
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